Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical lidocaine 5% for peripheral neuropathic pain: correlation of pain relief with A-delta and C-fiber function
2011-002083-25Phase 2Active
- Sponsor
- BG Universitätsklinikum Bergmannsheil
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of lidocaine in Peripheral neuropathic pain and postherpetic neuralgia (PHN), sponsored by BG Universitätsklinikum Bergmannsheil. Primary endpoint: Pain relief (NRS-3). Started Jul 2011; status: active.
02
Drugs
lidocaine
03
Conditions
Peripheral neuropathic painpostherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2011-002083-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002083-25.